David H. Gutmann

Affiliations: 
Biology and Biomedical Sciences (Neurosciences) Washington University, Saint Louis, St. Louis, MO 
Area:
Cell Biology, Oncology, Neuroscience Biology
Google:
"David Gutmann"
Mean distance: 53433
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Li K, Turner AN, Chen M, et al. (2016) Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I. Disease Models & Mechanisms. 9: 759-767
Smithson LJ, Gutmann DH. (2016) Proteomic analysis reveals GIT1 as a novel mTOR complex component critical for mediating astrocyte survival. Genes & Development. 30: 1383-8
Smithson LJ, Anastasaki C, Chen R, et al. (2016) Contextual signaling in cancer. Seminars in Cell & Developmental Biology
Gutmann DH. (2016) Exploring the genetic basis for clinical variation in neurofibromatosis type 1. Expert Review of Neurotherapeutics
Johnson KJ, Zoellner NL, Gutmann DH. (2016) Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1. Cancer Epidemiology. 42: 53-59
Chen YH, Cimino PJ, Luo J, et al. (2016) ABCG1 maintains high-grade glioma survival in vitro and in vivo. Oncotarget
Zafar R, Hsiao EY, Botteron KN, et al. (2016) De novo development of gliomas in a child with neurofibromatosis type 1, fragile X and previously normal brain magnetic resonance imaging. Radiology Case Reports. 11: 33-5
Schwetye KE, Joseph NM, Al-Kateb H, et al. (2016) Gliosarcomas lack BRAF(V600E) mutation, but a subset exhibit β-catenin nuclear localization. Neuropathology : Official Journal of the Japanese Society of Neuropathology
Anderson DM, Van de Plas R, Rose KL, et al. (2016) 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma. Journal of Proteomics
Hirbe AC, Dahiya S, Friedmann-Morvinski D, et al. (2016) Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation. Oncotarget
See more...